88 related articles for article (PubMed ID: 7916898)
1. Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
Brunton VG; Lear MJ; Robins DJ; Williamson S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):291-309. PubMed ID: 7916898
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties.
Brunton VG; Lear MJ; McKeown P; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):463-83. PubMed ID: 8836111
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitors.
Brunton VG; Kelland LR; Lear MJ; Montgomery GJ; Robertson JH; Robins DJ; Queen J; Workman P
Anticancer Drug Des; 1996 Jun; 11(4):265-95. PubMed ID: 8679052
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of unsaturated quinoline derivatives.
Montgomery GJ; McKeown P; McGown AT; Robins DJ
Anticancer Drug Des; 2000 Jun; 15(3):171-81. PubMed ID: 11049085
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
Reddy KB; Mangold GL; Tandon AK; Yoneda T; Mundy GR; Zilberstein A; Osborne CK
Cancer Res; 1992 Jul; 52(13):3636-41. PubMed ID: 1617636
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
7. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
8. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
9. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.
Yoneda T; Lyall RM; Alsina MM; Persons PE; Spada AP; Levitzki A; Zilberstein A; Mundy GR
Cancer Res; 1991 Aug; 51(16):4430-5. PubMed ID: 1651159
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells.
Piontek M; Hengels KJ; Porschen R; Strohmeyer G
Anticancer Res; 1993; 13(6A):2119-23. PubMed ID: 8297123
[TBL] [Abstract][Full Text] [Related]
11. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
Ramdas L; McMurray JS; Budde RJ
Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative properties of 4-aminoquinazoline derivatives as inhibitors of EGF receptor-associated tyrosine kinase activity.
Bouey-Bencteux E; Loison C; Pommery N; Houssin R; Hénichart JP
Anticancer Drug Des; 1998 Dec; 13(8):893-922. PubMed ID: 10335266
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
Posner I; Engel M; Gazit A; Levitzki A
Mol Pharmacol; 1994 Apr; 45(4):673-83. PubMed ID: 8183246
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways.
Klein SB; Fisher GJ; Jensen TC; Mendelsohn J; Voorhees JJ; Elder JT
J Cell Physiol; 1992 May; 151(2):326-36. PubMed ID: 1572907
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) modulates fetal thymocyte growth and differentiation: partial reversal by insulin, mimicking by specific inhibitors of EGF receptor tyrosine kinase activity, and differential expression of CD45 phosphatase isotypes.
Freitas CS; Dalmau SR; Savino W
J Immunol; 1998 Oct; 161(7):3384-92. PubMed ID: 9759855
[TBL] [Abstract][Full Text] [Related]
19. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
Hoffman R; Dennis IF; Donaldson J
Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
[TBL] [Abstract][Full Text] [Related]
20. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
Fan Z; Masui H; Altas I; Mendelsohn J
Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
